Not all acute peripheral facial palsy in children recovers completely: A telediagnostic follow-up study

Sarah Christine Stapperfend1, Katharina Geißler1, Jonas Ballmaier1

  • 1Department of Otorhinolaryngology, Facial-Nerve-Center, Jena University Hospital, Jena, Germany; Center for Rare Diseases, Jena University Hospital, Jena, Germany.

Insights

Approximately 21.4% of children with Bell's palsy develop synkinesis, impacting their recovery. Further research is needed to understand corticosteroid use in pediatric facial palsy (FP).

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Otolaryngology

Background:

  • Peripheral facial palsy (FP) affects adults, with up to 30% developing synkinesis.
  • The incidence of synkinesis in children with FP is not well-established due to limited long-term data.

Purpose of the Study:

  • To determine the incidence and long-term outcomes of synkinesis in children treated for acute peripheral FP.
  • To evaluate functional impairments and mental health effects associated with pediatric FP.

Main Methods:

  • Cross-sectional study of children (<18 years) treated for acute peripheral FP between 2009-2021.
  • Included Bell's palsy and infection-associated FP; excluded secondary causes.
  • Utilized video follow-ups, PROMs (FaCE, FDI, SAQ), and video-based assessments (Sunnybrook, eFACE).

Main Results:

  • 26 children participated (30.6% response rate); mean age at onset 8.5 years.
  • Idiopathic FP (IFP) and Lyme-associated FP (LFP) groups showed high recovery rates (eFACE/Sunnybrook scores 90-100).
  • Synkinesis developed in 28.6% of IFP patients, with functional impairments noted. Mental health effects reported by 35.7% of IFP and 16.7% of LFP patients.

Conclusions:

  • A significant proportion (21.4%) of children with Bell's palsy may develop moderate to severe synkinesis.
  • Long-term follow-up is crucial for understanding pediatric FP outcomes.
  • Further research on corticosteroid use in pediatric FP is warranted.
Abstract

Related Concept Videos